The Michigan Institute for Clinical & Health Research (MICHR) launched a COVID-19 Rapid Response Research Registry to offer a centralized clinical characterization and management resource of what the scientific and health care community has learned through the public health pandemic. The Registry will gather data from coronavirus patients in order to inform front-line clinical care decisions in real-time, trends in treatments, hospital-level projections, and future research designs. For an overview of MICHR COVID-19 related services, see here. For a free consultation, contact the MICHR COVID-19 Rapid Response Research Registry team here.